Kmart 2001 results
This article was originally published in The Rose Sheet
Executive SummaryNet sales for fiscal 2001 (ended Jan. 30) decreased 2.4% to $36.15 bil. and retailer reports a net loss of $2.42 bil., compared with a $244 mil. deficit the previous year. Kmart also restates losses reported during first three quarters of the year based on "an adjustment for an indeterminate amount of supplemental or incremental vendor allowances that were initially recorded" during the quarters prior to having been documented, Kmart says. Performance attributed to unsuccessful marketing initiatives and erosion in supplier confidence. Firm also took $979 mil. charge to write down assets in Q4 related to store closings...
You may also be interested in...
US FDA officials tell industry that implementing a quality metrics program is an agency priority and that a rejiggered program will incorporate various elements of other quality metrics initiatives being piloted by the agency, industry and academia.
Sanofi eyes $1bn top line growth from OTC switches of ED drug Cialis and flu drug Tamiflu after they launch by 2026, says CEO Paul Hudson. Like switch consultants, though, he acknowledges the high bar for approval moving additional Rx ingredients to OTC.
Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.